Answers are grounded in this paper and cite their sources.
Without exception, ninety-eight strains of haemolytic streptococci isolated from scarlet fever cases have been found to produce a toxic principle which in high dilutions is capable of evoking a cutaneous reaction in sus ceptible persons. 2. A certain proportion of haemolytic streptococci from other sources possess a similar toxigenic property. In the majority of such cases this property is only weakly developed as judged by quantitative tests. In a few instances a “toxin” is produced which is equally active with that of scarlatina strains. 3. Certain non-scarlatina strains produce “toxins” which evoke a cutane ous reaction both in known positive reactors and also in persons who do not react to a standard toxin from a scarlatina strain. 4. In the majority of cases the toxins produced by scarlatina strains are neutralised by the scarlatina antitoxic sera at present being used for therapeutic purposes, but a certain proportion of such toxins are not in the neutralised 5. The “toxins”produced by non-scaralation strains are in the majority of cases neutralised by the antitoxic sera.
No takes yet. Share an insight, caveat, or question.
D. G. S. Mclachlan (1927) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: